Kerala Govt Study Busts Myth Around COVID Vaccine-Related Death, Says No Evidence To Back Claims

The study stated that claims linking vaccines to heart attacks in young people, often made by anti-vaccine advocates, were not supported by data.

The study found no significant increase in unexplained sudden deaths among individuals aged 18-45 following Covid vaccination.

Source : PTI

Contrary to the belief that Covid-19 vaccinations have caused a spike in deaths among young adults, data from the Kerala government shows no abnormal increase in death rates within the 35-44 age group between 2019 and 2023.

A report by The New Indian Express suggests that mortality rates in this age bracket were 3.30% in 2019 and remained steady post-vaccination, at 3.13% in 2022 and 3.23% in 2023.

The study stated that claims linking vaccines to heart attacks in young people, often made by anti-vaccine advocates, were not supported by data. It furthed stated that there is no evidence connecting vaccinations to an increase in deaths in this demographic.

Though research on premature deaths in Kerala is limited, the available mortality statistics align with health experts’ reassurances about the safety of Covid-19 vaccines. In the 18-44 age group, 1,29,45,396 people in Kerala received the first dose, and 1,08,60,254 went on to receive the second dose.

“The assumption that vaccines are to blame for any death among young individuals is misguided. While vaccines can occasionally lead to rare complications, these instances are extremely uncommon, as reflected in the mortality data,” said Dr. V. Ramankutty, an epidemiologist and emeritus professor at Sree Chitra Tirunal Institute for Medical Sciences & Technology, in a statement to The New Indian Express.

What Did The Study Say About Sudden Deaths Among Youths?

A 2023 study by the National Institute of Epidemiology, conducted across multiple centers, also found no significant increase in unexplained sudden deaths among individuals aged 18-45 following Covid vaccination.

Kerala began its vaccine rollout on January 13, 2021, administering Covishield (produced by the Serum Institute of India under license from Oxford-AstraZeneca) and Covaxin (developed by Bharat Biotech).

According to a Lancet study published in June 2022, Covid-19 vaccinations in India prevented an estimated 4.2 million deaths between December 8, 2020, and December 8, 2021.

“In India, we estimate that 42,10,000 deaths were avoided due to vaccinations during this timeframe, with the margin of uncertainty ranging from 36,65,000 to 43,70,000,” said Oliver Watson, lead author of the study from Imperial College London, in an email to PTI.

“This analysis highlights the enormous life-saving impact of India’s vaccination campaign, particularly as it was among the first nations to face the Delta variant’s severe effects,” Watson added.